Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1988 Mar-Apr;61(2):105–113.

Cocaine: analysis, pharmacokinetics, and metabolic disposition.

P Jatlow 1
PMCID: PMC2590277  PMID: 3043924

Abstract

The ability to measure concentrations of cocaine in body fluids can contribute substantially to any investigation of cocaine's pharmacological effects. Design of research which involves the administration of cocaine must take into account current knowledge regarding the drug's pharmacokinetics. Cocaine's very rapid elimination from the body should be considered in attempting to understand patterns of cocaine abuse, and such phenomena as bingeing and acute tolerance. Accurate analysis of cocaine and/or its metabolites is essential to the diagnosis and evaluation of cocaine use whether for medical or forensic purposes. Appropriate selection of methods for analysis of cocaine depends upon the intended purpose of the assay, and correct interpretation of the data obtained upon knowledge of cocaine's kinetics and metabolic disposition.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambre J. J., Ruo T. I., Smith G. L., Backes D., Smith C. M. Ecgonine methyl ester, a major metabolite of cocaine. J Anal Toxicol. 1982 Jan-Feb;6(1):26–29. doi: 10.1093/jat/6.1.26. [DOI] [PubMed] [Google Scholar]
  2. Ambre J., Fischman M., Ruo T. I. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol. 1984 Jan-Feb;8(1):23–25. doi: 10.1093/jat/8.1.23. [DOI] [PubMed] [Google Scholar]
  3. Ambre J. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J Anal Toxicol. 1985 Nov-Dec;9(6):241–245. doi: 10.1093/jat/9.6.241. [DOI] [PubMed] [Google Scholar]
  4. Barnett G., Hawks R., Resnick R. Cocaine pharmacokinetics in humans. J Ethnopharmacol. 1981 Mar-May;3(2-3):353–366. doi: 10.1016/0378-8741(81)90063-5. [DOI] [PubMed] [Google Scholar]
  5. Chinn D. M., Crouch D. J., Peat M. A., Finkle B. S., Jennison T. A. Gas chromatography-chemical ionization mass spectrometry of cocaine and its metabolites in biological fluids. J Anal Toxicol. 1980 Jan-Feb;4(1):37–42. doi: 10.1093/jat/4.1.37. [DOI] [PubMed] [Google Scholar]
  6. Chow M. J., Ambre J. J., Ruo T. I., Atkinson A. J., Jr, Bowsher D. J., Fischman M. W. Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther. 1985 Sep;38(3):318–324. doi: 10.1038/clpt.1985.179. [DOI] [PubMed] [Google Scholar]
  7. Evans M. A., Harbison R. D. Cocaine-induced hepatotoxicity in mice. Toxicol Appl Pharmacol. 1978 Sep;45(3):739–754. doi: 10.1016/0041-008x(78)90167-9. [DOI] [PubMed] [Google Scholar]
  8. Fischman M. W., Schuster C. R., Javaid J., Hatano Y., Davis J. Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther. 1985 Dec;235(3):677–682. [PubMed] [Google Scholar]
  9. Freeman R. W., Harbison R. D. Hepatic periportal necrosis induced by chronic administration of cocaine. Biochem Pharmacol. 1981 Apr 1;30(7):777–783. doi: 10.1016/0006-2952(81)90165-9. [DOI] [PubMed] [Google Scholar]
  10. Hawks R. L., Kopin I. J., Colburn R. W., Thoa N. B. Norcocaine: a pharmacologically active metabolite of cocaine found in brain. Life Sci. 1974 Dec 15;15(12):2189–2195. doi: 10.1016/0024-3205(74)90035-6. [DOI] [PubMed] [Google Scholar]
  11. Holford N. H., Sheiner L. B. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981 Nov-Dec;6(6):429–453. doi: 10.2165/00003088-198106060-00002. [DOI] [PubMed] [Google Scholar]
  12. Hoyt D. W., Finnigan R. E., Nee T., Shults T. F., Butler T. J. Drug testing in the workplace--are methods legally defensible? A survey of experts, arbitrators, and testing laboratories. JAMA. 1987 Jul 24;258(4):504–509. doi: 10.1001/jama.1987.03400040102031. [DOI] [PubMed] [Google Scholar]
  13. Inaba T., Stewart D. J., Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther. 1978 May;23(5):547–552. doi: 10.1002/cpt1978235547. [DOI] [PubMed] [Google Scholar]
  14. Jacob P., 3rd, Elias-Baker B. A., Jones R. T., Benowitz N. L. Determination of cocaine in plasma by automated gas chromatography. J Chromatogr. 1984 Mar 9;306:173–181. doi: 10.1016/s0378-4347(00)80880-4. [DOI] [PubMed] [Google Scholar]
  15. Jatlow P. I., Bailey D. N. Gas-chromatographic analysis for cocaine in human plasma, with use of a nitrogen detector. Clin Chem. 1975 Dec;21(13):1918–1921. [PubMed] [Google Scholar]
  16. Jatlow P. I., Van Dyke C., Barash P., Byck R. Measurement of benzoylecgonine and cocaine in urine, separation of various cocaine metabolites using reversed-phase high-performance liquid chromatography. J Chromatogr. 1978 May 11;152(1):115–121. doi: 10.1016/s0021-9673(00)85340-6. [DOI] [PubMed] [Google Scholar]
  17. Jatlow P., Barash P. G., Van Dyke C., Radding J., Byck R. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg. 1979 May-Jun;58(3):235–238. [PubMed] [Google Scholar]
  18. Javaid J. I., Fischman M. W., Schuster C. R., Dekirmenjian H., Davis J. M. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science. 1978 Oct 13;202(4364):227–228. doi: 10.1126/science.694530. [DOI] [PubMed] [Google Scholar]
  19. Kloss M. W., Rosen G. M., Rauckman E. J. Cocaine-mediated hepatotoxicity. A critical review. Biochem Pharmacol. 1984 Jan 15;33(2):169–173. doi: 10.1016/0006-2952(84)90471-4. [DOI] [PubMed] [Google Scholar]
  20. Mulé S. J., Bastos M. L., Jukofsky D. Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse. Clin Chem. 1974 Feb;20(2):243–248. [PubMed] [Google Scholar]
  21. Mulé S. J., Jukofsky D., Kogan M., De Pace A., Verebey K. Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine. Clin Chem. 1977 May;23(5):796–801. [PubMed] [Google Scholar]
  22. Paly D., Jatlow P., Van Dyke C., Jeri F. R., Byck R. Plasma cocaine concentrations during cocaine paste smoking. Life Sci. 1982 Mar 1;30(9):731–738. doi: 10.1016/0024-3205(82)90606-3. [DOI] [PubMed] [Google Scholar]
  23. Perez-Reyes M., Di Guiseppi S., Ondrusek G., Jeffcoat A. R., Cook C. E. Free-base cocaine smoking. Clin Pharmacol Ther. 1982 Oct;32(4):459–465. doi: 10.1038/clpt.1982.189. [DOI] [PubMed] [Google Scholar]
  24. Stewart D. J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther. 1979 Apr;25(4):464–468. doi: 10.1002/cpt1979254464. [DOI] [PubMed] [Google Scholar]
  25. Stewart D. J., Inaba T., Tang B. K., Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci. 1977 May 1;20(9):1557–1563. doi: 10.1016/0024-3205(77)90448-9. [DOI] [PubMed] [Google Scholar]
  26. Thompson M. L., Shuster L., Shaw K. Cocaine-induced hepatic necrosis in mice--the role of cocaine metabolism. Biochem Pharmacol. 1979 Aug 1;28(15):2389–2395. doi: 10.1016/0006-2952(79)90705-6. [DOI] [PubMed] [Google Scholar]
  27. Van Dyke C., Barash P. G., Jatlow P., Byck R. Cocaine: plasma concentrations after intranasal application in man. Science. 1976 Feb 27;191(4229):859–861. doi: 10.1126/science.56036. [DOI] [PubMed] [Google Scholar]
  28. Van Dyke C., Byck R. Cocaine. Sci Am. 1982 Mar;246(3):128–141. doi: 10.1038/scientificamerican0382-128. [DOI] [PubMed] [Google Scholar]
  29. Van Dyke C., Jatlow P., Ungerer J., Barash P. G., Byck R. Oral cocaine: plasma concentrations and central effects. Science. 1978 Apr 14;200(4338):211–213. doi: 10.1126/science.24895. [DOI] [PubMed] [Google Scholar]
  30. Wallace J. E., Hamilton H. E., Schwertner H., King D. E., McNay J. L., Blum K. Thin-layer chromatographic analysis of cocaine and benzoylecgonine in urine. J Chromatogr. 1975 Nov 26;114(2):433–441. doi: 10.1016/s0021-9673(01)92008-4. [DOI] [PubMed] [Google Scholar]
  31. Wilkinson P., Van Dyke C., Jatlow P., Barash P., Byck R. Intranasal and oral cocaine kinetics. Clin Pharmacol Ther. 1980 Mar;27(3):386–394. doi: 10.1038/clpt.1980.52. [DOI] [PubMed] [Google Scholar]
  32. Zahler R., Wachtel P., Jatlow P., Byck R. Kinetics of drug effect by distributed lags analysis: an application to cocaine. Clin Pharmacol Ther. 1982 Jun;31(6):775–782. doi: 10.1038/clpt.1982.110. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES